Table 6 Risk of Hypertension in the entire participants according to plasma marker quartiles.

From: The relationship between Plasma Markers and Essential Hypertension in Middle-aged and Elderly Chinese Population: A Community Based Cross-sectional Study

Plasma Marker

Plasma markers

Quartile 1

Quartile 2

Quartile 3

Quartile 4

hs-CRP

≤0.50

0.51–1.01

1.02–1.94

≥1.95

Model 1

1.000(ref.)

1.35(1.08–1.67)‡

1.94(1.54–2.43)‡

1.83(1.46–2.30)‡

Model 2

1.000(ref.)

1.17(0.93–1.47)

1.51(1.19–1.91)†

1.30(1.02–1.66)*

Model 3

1.000(ref.)

1.10(0.88–1.39)

1.41(1.11–1.80)*

1.17(0.91–1.51)

Hcy

≤7.97

7.98–9.47

9.48–11.92

≥1.93

Model 1

1.000(ref.)

1.09(0.87–1.35)

1.22(0.97–1.53)

1.59(1.26–2.01)‡

Model 2

1.000(ref.)

1.06(0.84–1.33)

1.17(0.92–1.47)

1.52(1.19–1.94)‡

Model 3

1.000(ref.)

1.09(0.87–1.37)

1.17(0.92–1.47)

1.48(1.16–1.90)†

hs-TnT

≤5.82

5.83–7.92

7.93–10.23

≥10.24

Model 1

1.000(ref.)

1.15(0.91–1.46)

1.19(0.93–1.51)

1.21(0.94–1.55)

Model 2

1.000(ref.)

1.16(0.91–1.48)

1.16(0.91–1.49)

1.08(0.83–1.39)

Model 3

1.000(ref.)

1.16(0.91–1.49)

1.15(0.90–1.48)

1.05(0.81–1.37)

NT-proBNP

≤30.75

30.75–50.77

50.78–83.79

≥83.80

Model 1

1.000(ref.)

1.13(0.90–1.41)

1.06(0.85–1.32)

1.31(1.04–1.65)*

Model 2

1.000(ref.)

1.25(0.99–1.57)

1.18(0.93–1.49)

1.53(1.21–1.95)*

Model 3

1.000(ref.)

1.28(1.02–1.62)

1.24(0.98–1.56)

1.62(1.27–2.07)‡

25-OHD

≤9.85

9.86–13.95

13.96–13.39

≥19.40

Model 1

1.000(ref.)

0.81(0.65–1.01)

0.85(0.68–1.07)

0.99(0.79–1.25)

Model 2

1.000(ref.)

0.80(0.64–1.01)

0.84(0.66–1.06)

0.95(0.75–1.21)

Model 3

1.000(ref.)

0.81(0.65–1.03)

0.85(0.67–1.08)

0.97(0.76–1.24)

HBA1C (%)

≤4.72

4.73–5.09

5.10–5.66

≥5.67

Model 1

1.000(ref.)

1.08(0.87–1.34)

1.21(0.97–1.51)

2.31(1.84–2.90)‡

Model 2

1.000(ref.)

1.08(0.87–1.35)

1.21(0.97–1.50)

2.31(1.84–2.91)‡

Model 3

1.000(ref.)

1.06(0.85–1.33)‡

1.11(0.88–1.39)

1.94(1.49–2.52)‡

Model 4

1.000(ref.)

1.06(0.85–1.34)

1.10(0.88–1.39)

1.96(1.51–2.56)‡

SUA #

Model 1

1.000(ref.)

0.99(0.80–1.23)

1.08(0.87–1.35)

1.71(1.37–2.14)

Model 2

1.000(ref.)

0.90(0.72–1.12)

0.87(0.69–1.09)

1.23(0.97–1.56)

Model 3

1.000(ref.)

0.87(0.69–1.09)

0.83(0.66–1.05)

1.11(0.87–1.41)

  1. *P < 0.05; †P < 0.01; ‡P < 0.001.
  2. #The cutoff points for the Serum Uric Acid were calculated for men and women separately, and the values are described in Tables 4 and 5.
  3. hs-CRP = high-sensitivity C-reactive protein; hs-cTnT, high-sensitivity cardiac troponin T; NT-proBNP, N-terminal prohormone of brain natriuretic peptide; 25OHD, 25-Hydroxyvitamin D; SUA, serum uric acid and HbA1c, glycosylated hemoglobin A1c.
  4. Model 1: Adjusted for age and gender.
  5. Model 2: Adjusted for age, gender, smoking, Alcohol use, physical activity.
  6. Model 3: Adjusted for the above plus total serum cholesterol, high-density lipoprotein, LDL-C, triglycerides and creatinine, BMI and Diabetes Mellitus.
  7. Model 4: Sensitivity analysis for HBA1c markers.
Back to article page